These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


688 related items for PubMed ID: 11079584

  • 1. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
    Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.
    Clin Nucl Med; 2000 Nov; 25(11):882-7. PubMed ID: 11079584
    [Abstract] [Full Text] [Related]

  • 2. Role of positron emission tomography in staging esophageal cancer.
    Luketich JD, Schauer PR, Meltzer CC, Landreneau RJ, Urso GK, Townsend DW, Ferson PF, Keenan RJ, Belani CP.
    Ann Thorac Surg; 1997 Sep; 64(3):765-9. PubMed ID: 9307471
    [Abstract] [Full Text] [Related]

  • 3. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
    Kneist W, Schreckenberger M, Bartenstein P, Grünwald F, Oberholzer K, Junginger T.
    Chirurg; 2003 Oct; 74(10):922-30; discussion 929-30. PubMed ID: 14605734
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, Xu G, Yang W, Zhao S.
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [Abstract] [Full Text] [Related]

  • 5. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL.
    J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
    [Abstract] [Full Text] [Related]

  • 6. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
    Tan R, Yao SZ, Huang ZQ, Li J, Li X, Tan HH, Liu QW.
    Asian Pac J Cancer Prev; 2014 Aug; 15(18):7719-24. PubMed ID: 25292052
    [Abstract] [Full Text] [Related]

  • 7. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
    Westerterp M, Van Westreenen HL, Sloof GW, Plukker JT, Van Lanschot JJ.
    Scand J Gastroenterol Suppl; 2006 Aug; (243):116-22. PubMed ID: 16782630
    [Abstract] [Full Text] [Related]

  • 8. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
    Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, Tsukada K, Oriuchi N, Inoue T, Endo K.
    Cancer; 2002 Feb 15; 94(4):921-8. PubMed ID: 11920459
    [Abstract] [Full Text] [Related]

  • 9. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
    Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS.
    Radiology; 2003 Jun 15; 227(3):764-70. PubMed ID: 12773680
    [Abstract] [Full Text] [Related]

  • 10. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
    Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L.
    J Clin Oncol; 2000 Sep 15; 18(18):3202-10. PubMed ID: 10986052
    [Abstract] [Full Text] [Related]

  • 11. [Impact of (18)F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer].
    Pifarré-Montaner P, Fernández-León A, de Juan R, del Ama-Salvador ME, Galán M, Gámez-Cenzano C, Sans M.
    Rev Esp Med Nucl; 2009 Sep 15; 28(3):101-5. PubMed ID: 19558949
    [Abstract] [Full Text] [Related]

  • 12. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
    Malik V, Harmon M, Johnston C, Fagan AJ, Claxton Z, Ravi N, O'Toole D, Muldoon C, Keogan M, Reynolds JV, Meaney JF.
    Dig Surg; 2015 Sep 15; 32(5):397-408. PubMed ID: 26315570
    [Abstract] [Full Text] [Related]

  • 13. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
    Yuan S, Yu Y, Chao KS, Fu Z, Yin Y, Liu T, Chen S, Yang X, Yang G, Guo H, Yu J.
    J Nucl Med; 2006 Aug 15; 47(8):1255-9. PubMed ID: 16883002
    [Abstract] [Full Text] [Related]

  • 14. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.
    Cancer; 2005 Jan 01; 103(1):148-56. PubMed ID: 15558794
    [Abstract] [Full Text] [Related]

  • 15. Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.
    Gajjala SR, Hulikal N, Kadiyala S, Kottu R, Kalawat T.
    Indian J Med Res; 2018 Mar 01; 147(3):256-262. PubMed ID: 29923514
    [Abstract] [Full Text] [Related]

  • 16. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
    Junginger T, Kneist W, Schreckenberger M, Menzel C, Oberholzer K, Bartenstein P.
    Dtsch Med Wochenschr; 2002 Sep 20; 127(38):1935-41. PubMed ID: 12239652
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
    Manabe O, Hattori N, Hirata K, Itoh K, Hosokawa M, Takahashi H, Oyama-Manabe N, Tamaki N.
    J Nucl Med; 2013 May 20; 54(5):670-6. PubMed ID: 23516310
    [Abstract] [Full Text] [Related]

  • 18. Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography.
    van Westreenen HL, Heeren PA, Jager PL, van Dullemen HM, Groen H, Plukker JT.
    Ann Surg Oncol; 2003 Nov 20; 10(9):1100-5. PubMed ID: 14597450
    [Abstract] [Full Text] [Related]

  • 19. Detection of distant metastases in esophageal cancer with (18)F-FDG PET.
    Heeren PA, Jager PL, Bongaerts F, van Dullemen H, Sluiter W, Plukker JT.
    J Nucl Med; 2004 Jun 20; 45(6):980-7. PubMed ID: 15181133
    [Abstract] [Full Text] [Related]

  • 20. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE, Wong WL, Mattheou AK, Damani N, Chambers J, Livingstone JI.
    Int J Surg; 2007 Dec 20; 5(6):399-403. PubMed ID: 17631431
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.